Kim Kamdar, PhD, Managing Partner at Medical Excellence Capital, a life sciences venture capital firm focused on early stage investing. She has also been a long-term Partner at Domain Associates. She is currently Chairman of the Board of Directors of Sera Prognostics (NASDAQ: SERA) and is co-founder and Chair of Seraphina Therapeutics and Truvian Sciences. She also serves on the board of directors of Alume, Epic Sciences, Pleno and Singular Genomics (NASDAQ: OMIC).